Cogent Biosciences, Inc. (COGT)
34.42
-0.58
(-1.66%)
USD |
NASDAQ |
Sep 01, 14:05
Cogent Biosciences Cash from Operations (TTM) : -307.54M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -307.54M |
| March 31, 2026 | -284.82M |
| December 31, 2025 | -264.44M |
| September 30, 2025 | -245.92M |
| June 30, 2025 | -233.61M |
| March 31, 2025 | -221.77M |
| December 31, 2024 | -207.79M |
| September 30, 2024 | -191.28M |
| June 30, 2024 | -177.27M |
| March 31, 2024 | -166.64M |
| December 31, 2023 | -153.62M |
| September 30, 2023 | -138.96M |
| June 30, 2023 | -135.43M |
| March 31, 2023 | -129.82M |
| December 31, 2022 | -118.64M |
| September 30, 2022 | -110.01M |
| Date | Value |
|---|---|
| June 30, 2022 | -89.68M |
| March 31, 2022 | -75.73M |
| December 31, 2021 | -58.76M |
| September 30, 2021 | -47.35M |
| June 30, 2021 | -43.51M |
| March 31, 2021 | -39.32M |
| December 31, 2020 | -35.85M |
| September 30, 2020 | -34.93M |
| June 30, 2020 | -34.87M |
| March 31, 2020 | -37.89M |
| December 31, 2019 | -41.51M |
| September 30, 2019 | -42.09M |
| June 30, 2019 | -39.46M |
| March 31, 2019 | -36.03M |
| December 31, 2018 | -32.49M |
| September 30, 2018 | -29.98M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Apogee Therapeutics, Inc. | -243.89M |
| Erasca, Inc. | -98.02M |
| Moderna, Inc. | -1.073B |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |